Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

Ibrahim El‐Battrawy(German Centre for Cardiovascular Research), Xiaobo Zhou(Heidelberg University), Xuehui Fan(Heidelberg University), Boldizsar Kovacs(University of Bern), Zhenxing Liao(Heidelberg University), Jonas Müller(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alyssa Hohn(Heidelberg University), Ardan M. Saguner(Zurich Heart House), Rujia Zhong(Heidelberg University), Hendrik Dinkel(Heidelberg University), Assem Aweimer(BG University Hospital Bergmannsheil Bochum), Siegfried Lang(Heidelberg University), İbrahim Akın(Heidelberg University), Andreas Mügge(Roche (Switzerland)), Fırat Duru(University of Zurich), Lasse Maywald(Heidelberg University), Eliane Duperrex, Lukas Cyganek(Universitätsmedizin Göttingen), Yingrui Li(BGI Group (China)), Mandy Kleinsorge(Zurich Heart House), Sebastian Diecke(Max Delbrück Center), Sebastian Albers(Heidelberg University), Lena Rose(Heidelberg University), Feng Zhang(Heidelberg University), Guang Li(Capital Medical University), Ji‐Hyun Lee(Korea Institute of Radiological and Medical Sciences), Zhen Yang(Heidelberg University), Qiao Lin(China Medical University), Qiang Xu(Nanjing University), Andreas Hierlemann, Huan Lan(Southwest Medical University), Mengying Huang(Heidelberg University)
Clinical and Translational Medicine
December 1, 2021
Cited by 22


Related Papers